RECRUITING

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking

Talk to us

Conditions

Charcot-Marie-Tooth DiseaseHealthyCharcot-Marie-Tooth

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Charcot-Marie-Tooth disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Charcot-Marie-Tooth disease.

Official Title

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking

Quick Facts

Study Start:2022-09-22
Study Completion:2025-09-22
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06203093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 5 years or older.
  2. * Diagnosis of Charcot-Marie-Tooth (CMT) disease or healthy controls.
  3. * Adults must provide written informed consent unless physical limitations preclude signing.
  4. * Minors undergoing skin collection for research purposes must have a CMT diagnosis and must participate with parent/guardian consent.
  5. * Minors undergoing blood and/or saliva collection for research purposes or who transfer biological samples from a procedure outside the research may have a CMT diagnosis or serve as a healthy control and may participate with parent/guardian consent.
  1. * Wards of the state.
  2. * For prospective skin samples: history of keloid formation, coagulation disorder, allergy to the anesthetic, or anticoagulation use that precludes sample collection.
  3. * For prospective blood samples: coagulation disorder or other medical conditions that increase the risks associated with blood collection.
  4. * For all prospective sample collections: Subjects who refuse to adhere to NYSCF's and/or a collaborating site's safety protocols will be excluded. Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter of blood will be excluded due to increased risk of infection.

Contacts and Locations

Study Contact

Becca Wood
CONTACT
212-927-1801
clinicalresearch@nyscf.org

Principal Investigator

Laura Andres-Martin
PRINCIPAL_INVESTIGATOR
New York Stem Cell Foundation Research Institute

Study Locations (Sites)

New York Stem Cell Foundation Research Institute
New York, New York, 10019
United States

Collaborators and Investigators

Sponsor: New York Stem Cell Foundation Research Institute

  • Laura Andres-Martin, PRINCIPAL_INVESTIGATOR, New York Stem Cell Foundation Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-22
Study Completion Date2025-09-22

Study Record Updates

Study Start Date2022-09-22
Study Completion Date2025-09-22

Terms related to this study

Keywords Provided by Researchers

  • Charcot-Marie-Tooth

Additional Relevant MeSH Terms

  • Charcot-Marie-Tooth Disease
  • Healthy